Anika Therapeutics Delivers Strong Performance with Record Product Revenue for the Fourth Quarter and Full Year 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. GOOGL

Go back to Anika Therapeutics Delivers Strong Performance with Record Product Revenue for the Fourth Quarter and Full Year 2015

Anika Therapeutics (ANIK) Tops Q4 EPS by 12c

February 24, 2016 4:16 PM EST

Anika Therapeutics (NASDAQ: ANIK) reported Q4 EPS of $0.72, $0.12 better than the analyst estimate of $0.60. Revenue for the quarter came in at $25.6 million versus the consensus estimate of $28.19 million.

We ended 2015 and entered 2016 with strong momentum in all aspects of our business -- commercial, clinical,... More